Published in Can J Microbiol on July 01, 1976
Symbiotic properties of C4-dicarboxylic acid transport mutants of Rhizobium leguminosarum. J Bacteriol (1983) 2.19
Effects of abiotic factors on acetylene reduction by cyanobacteria epiphytic on moss at a subantarctic island. Appl Environ Microbiol (1984) 0.85
Identification of beijerinckia in the high arctic (devon island, northwest territories). Appl Environ Microbiol (1978) 0.75
Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg (2006) 3.10
Symbiotic properties of C4-dicarboxylic acid transport mutants of Rhizobium leguminosarum. J Bacteriol (1983) 2.19
Succinate transport in Rhizobium leguminosarum. J Bacteriol (1981) 2.04
[Effectiveness of smoking cessation intervention in patients with cardiovascular disease]. Rev Esp Cardiol (2001) 1.93
Ultrastructure of root nodules formed by ineffective strains of Rhizobium meliloti. Can J Microbiol (1974) 1.30
Meta-analysis of observational studies on the safety and effectiveness of robotic gynaecological surgery. Br J Surg (2010) 1.23
Electron microscopy of the bacteroids and root nodules of Lupinus luteus. Can J Microbiol (1965) 1.21
Biological nitrogen fixation in the terrestrial environment of a high Arctic ecosystem (Truelove Lowland, Devon Island, N.W.T.). Can J Microbiol (1978) 1.21
Colorimetric determination of catechol siderophores in microbial cultures. Anal Biochem (1983) 1.20
On the cytology and synthetic capacities of natural and artificially produced bacteroids of Rhizobium leguminosarum. Can J Microbiol (1965) 1.19
A strategy for patient involvement in clinical practice guidelines: methodological approaches. BMJ Qual Saf (2011) 1.15
Ultrastructure of free-living and nitrogen-fixing forms of Rhizobium meliloti as revealed by freeze-etching. J Bacteriol (1973) 1.15
Iron requirement of Rhizobium leguminosarum and secretion of anthranilic acid during growth on an iron-deficient medium. Arch Biochem Biophys (1986) 1.09
Satisfaction with and psychological impact of immediate and deferred breast reconstruction. Ann Oncol (2008) 1.00
Anthranilate-promoted iron uptake in Rhizobium leguminosarum. Arch Biochem Biophys (1986) 0.96
Use of the Chrome Azurol S Agar Plate Technique To Differentiate Strains and Field Isolates of Rhizobium leguminosarum biovar trifolii. Appl Environ Microbiol (1989) 0.94
Further examination of presumptive Rhizobium trifolii mutants that nodulate Glycine max. Proc Natl Acad Sci U S A (1979) 0.93
Mode of action of viomycin on Rhizobium meliloti. Can J Microbiol (1969) 0.86
[Middle molecules removal. Beyond beta2-microglobulin]. Nefrologia (2006) 0.83
Coproporphyrin excretion by Rhizobium meliloti. Can J Microbiol (1969) 0.83
Cell wall phospholipid and viomycin resistance in Rhizobium meliloti. Biochem Biophys Res Commun (1970) 0.82
Laboratory production and 14 C-labelling of viomycin. J Antibiot (Tokyo) (1972) 0.81
A systematic review of FDG-PET in breast cancer. Med Oncol (2009) 0.80
Apparent absence of relationship between repair of single strand breaks in DNA and gamma radiation resistance in Salmonella thompson. Arch Mikrobiol (1970) 0.79
Explicit criteria for hospital admission in exacerbations of chronic obstructive pulmonary disease. Int J Tuberc Lung Dis (2011) 0.79
Predictors of hospital admission in exacerbations of chronic obstructive pulmonary disease. Int J Tuberc Lung Dis (2013) 0.78
Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension. Am J Hypertens (1988) 0.77
Effectiveness, safety, and cost-effectiveness of photodynamic therapy in Barrett's esophagus: a systematic review. Dis Esophagus (2010) 0.76
Overall safety of terazosin as an antihypertensive agent. Am J Med (1986) 0.76
Relationship of sociodemographic variables with outcomes after cataract surgery. Eye (Lond) (2013) 0.75
A comparison of carteolol and nadolol in the treatment of stable angina pectoris. J Clin Pharmacol (1988) 0.75
Ineffectiveness of viomycin-resistant mutants of Rhizobium meliloti. Can J Microbiol (1969) 0.75
A new nitrogen-fixing Clostridium species from a high Arctic ecosystem. Can J Microbiol (1979) 0.75
Inhibition by viomycin of cell-free protein synthesis in sensitive and resistant strains of Rhizobium meliloti. Can J Biochem (1969) 0.75
Efficacy of terazosin as an antihypertensive agent. Am J Med (1986) 0.75
The mode of action of the antibiotic paromomycin on Staphylococcus aureus. Can J Microbiol (1966) 0.75
A new inorganic pyrophosphate utilizing bacterium from a stagnant lake. Can J Microbiol (1983) 0.75
Yellow Blotch of Pleurotus ostreatus. Appl Environ Microbiol (1985) 0.75
Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent. J Int Med Res (1986) 0.75
The effects of terazosin and methyclothiazide on blood pressure and serum lipids. Am Heart J (1989) 0.75
Effect of age and dose on the incidence of adverse events in the treatment of hypertension in patients receiving terazosin. J Clin Pharmacol (1992) 0.75
Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy. J Hypertens Suppl (1986) 0.75
Mode of action of viomycin on Rhizobium meliloti. J Gen Microbiol (1968) 0.75
The isolation of the plasma membrane from a gram-negative organism. Prep Biochem (1973) 0.75
Cell-wall composition and viomycin resistance in Rhizobium meliloti. Can J Microbiol (1972) 0.75
Effect of age on the pharmacokinetics of orally and intravenously administered terazosin. Clin Ther (1988) 0.75
Pharmacologic effects of A-49816, a new high-ceiling diuretic. J Clin Pharmacol (1987) 0.75
Cation content and cation-exchange capacity of intact cells and cell envelopes of viomycin-sensitive and -resistant strains of Rhizobium meliloti. Can J Microbiol (1971) 0.75